Skip to main content
InventoryRef 8379415/10/2010

LIDOCAINE

Acetamide, 2-(diethylamino)-N-(2,6-dimethylphenyl)-

LIDOCAINE is linked to 1 EU annex record on this page. Inventory note: II/399.

Regulatory evidence by market

This matrix separates verified ingredient rules from sources that are mapped but not yet imported. No imported rule does not mean the ingredient is permitted.

Compare markets

Swipe or scroll horizontally to see every column.

MarketEvidence statusRecordsSource language
European UnionEvidence linked
Prohibited entry found
Open this evidence
1English and EU languages
Great BritainEvidence linked
Prohibited
Open this evidence
1English
CanadaEvidence linked
Prohibited
Open this evidence
1English and French
New ZealandEvidence linked
Prohibited
Open this evidence
1English
ASEANEvidence linked
Prohibited
Open this evidence
1English and national languages
ChinaEvidence linked
Prohibited
Open this evidence
1Chinese with selected English material
JapanSource mapped
Official source mapped; ingredient rule not imported
0Japanese; official English translation available
South KoreaEvidence linked
Prohibited
Open this evidence
1Korean with some English names
United StatesSource mapped
Official source mapped; ingredient rule not imported
0English
AustraliaSource mapped
Official source mapped; ingredient rule not imported
0English
BrazilEvidence linked
Prohibited
Open this evidence
1Portuguese with INCI crosswalks
IndiaEvidence linked
Prohibited
Open this evidence
1English and Hindi
Saudi ArabiaEvidence linked
Prohibited
Open this evidence
1Arabic and English

Chemical identity and properties

PubChem 2D chemical structure for CAS 137-58-6
CAS 137-58-6PubChem CID 3676

Lidocaine

Lidocaine is the monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline. It has a role as a xenobiotic, a local anaesthetic, an anti-arrhythmia drug, an environmental contaminant and a drug allergen. It is a member of benzenes, a monocarboxylic acid amide and a tertiary amino compound. It is functionally related to a glycinamide. ChEBI

IUPAC name
2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide
Molecular formula
C14H22N2O
Molecular weight
234.34 g/mol
Exact mass
234.173213330 Da
XLogP3
2.3
Topological polar surface area
32.3 Ų
Hydrogen-bond donors
1
Hydrogen-bond acceptors
2
Covalent units
1
Defined stereocentres
0

Also known as

XylocaineDuncaineLidodermXylestesinEsracaineGravocainIsicainaLeostesin
16 more reported names
MaricaineSolcainCappicaineSolarcaineIsicaineRucainaXycaineL-CaineAlphacaineXylotoxLida-MantleDentipatch2-(Diethylamino)-2',6'-acetoxylidideLidocainumCuivasilJetocaine
External database identifiers

Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.

Inventory details for LIDOCAINE

INCI name

LIDOCAINE

INN name

Lidocaine [USAN:INN:JAN]

Description

Acetamide, 2-(diethylamino)-N-(2,6-dimethylphenyl)-

Record provenance

Inventory reference
83794
Imported identity
LIDOCAINE
Source update
15/10/2010
European Commission CosIng source notes

Key data

Restriction
II/399
Function
NOT REPORTED
No function currently reported.

Official EU ingredient-name evidence

The ingredient name exactly matches the official 2025 EU glossary of common ingredient names.

Ingredients with overlapping formulation functions

Additional official and scientific sources

11 external databases to check this identity in

How LIDOCAINE appears in the CosIng inventory

The CosIng inventory lists LIDOCAINE as a cosmetic ingredient and this page links it to 1 annex record. The inventory entry captures names and identifiers, while the annex record shows where the substance is prohibited, restricted or positively listed in EU cosmetics law.

LIDOCAINE is also tagged with 1 cosmetic function in the official data. Function labels describe intended use, but they do not replace regulatory review of linked annex records before formulation or labelling work.

Frequently asked questions

LIDOCAINE appears in the EU CosIng inventory and has linked annex records. Check the annex records above for applicable restrictions, concentration limits and conditions of use. Annex II listing means prohibited; Annex III means restricted; Annexes IV, V and VI mean permitted under specified conditions.

The restriction field for LIDOCAINE reads: "II/399". This is the restriction note recorded in the CosIng inventory for this ingredient. For authoritative conditions and limits, always refer to the linked annex entries above.

According to the EU CosIng inventory, LIDOCAINE carries the following function designation(s):

CAS 137-58-6 may appear across multiple EU annex records. Viewing the CAS lookup page shows all Annex II–VI entries sharing this identifier, which is useful for identifying cross-annex regulatory status of the same chemical substance.

Use the INCI Checker to screen a full ingredient list across selected markets, or compare this substance across all supported market datasets.

Source note for LIDOCAINE

This page combines the CosIng inventory entry for LIDOCAINE with 1 linked Annex II–VI record from the local dataset built from public European Commission cosmetic ingredient materials.

Use this inventory page to research LIDOCAINE and compare linked records, but verify restrictions and legal status against the current official source text and law before making regulatory decisions.

Tools & next steps

Check your formula

Scan a full INCI list to detect LIDOCAINE and any linked EU annex restrictions or allergen flags.

INCI Checker

Search similar ingredients

Find other inventory ingredients and annex entries related to LIDOCAINE, its identifiers or nearby name variants.

Search